Carolina Institute for NanoMedicine (CINM) was established in 2010 as an umbrella program to support multidisciplinary nanotechnology research among investigators from variety of backgrounds including College of Arts & Sciences, UNC Eshelman School of Pharmacy, and UNC School of Medicine. The goal of CINM is to improve human health by enhancing the scientific knowledge as well as the transition of basic research discoveries into clinical trials. CINM harbors two centers: The Carolina Center of Cancer Nanotechnology Excellence (C-CCNE) and The Center for Nanotechnology in Drug Delivery (CNDD)
The center's mission is to pursue an integrated science and engineering program by utilizing emerging carbon nanotechnology to develop new materials, devices and systems. One of their unique strengths is applying advanced synthetic methods to the development of advanced carbon nanomaterials with well-defined, multidimensional structures for multifunctional applications, including electrochemical energy conversion and storage.
The Feng Research Group is working to explore fundamental physics and new engineering of nanoscale solid-state structures and devices. Their research efforts are primarily focused upon emerging nanoscale devices that have strong potential for enabling building blocks and components for novel circuits and transducers, which could lead to future generations of devices and integrated systems for advanced sensing, computing, and communication applications.
The recent EUREKA programme CATRENE (Cluster for Application and Technology Research in Europe on NanoElectronics) will effect Technological Leadership for a competitive European ICT industry. It is the ambition of Europe and the European companies to deliver nano-/microelectronics solutions that respond to the needs of society at large, improving the economic prosperity of Europe and reinforcing the ability of its industry to be at the forefront of the global competition. CATRENE builds on the successful previous EUREKA programmes JESSI, MEDEA, and MEDEA+ in fostering the continued development of a dynamic European ecosystem with the critical mass necessary to compete at a global level in high technology industries.
(Website in French) One of the largest applied research laboratories in Micro and Nanotechnologies in Europe, it focuses on microelectronics and microsystems on silicon, systems for biology and health, and optoelectronic and components.
The lab's goal is to understand the fundamental design principles of cellular control systems and to apply these principles to engineer cells or cell-like devices with novel, 'smart' therapeutic functions.
CellNanoTox, 'Cellular Interaction and Toxicology with Engineered Nanoparticles', is a Specific Targeted Research Project funded by the European Commission under the Sixth Framework Program. The project addresses the needs of the European society for assessing the risk of occupational and general population exposure to industrially manufactured nanoparticles. It is expected to generate new knowledge on potential health risk or the absence of it, providing objective arguments for recommendations and regulations.
CellPROM - beginning March 2004 - is the largest Integrated Project within the NMP priority of the 6th Framework Programme of the European Commission. CellPROM unites 27 academic and industrial researchers from 12 countries for a period of four years to achieve its main objective of non-invasive 'reprogramming' of individual cells on an industrial scale.
The purpose of CEMES is to manufacture, understand, model and manipulate matter at the atomic scale. In CEMES, physicists and chemists invent (nano) materials and molecules of desired properties and integrate them into demonstrating devices. CEMES mostly aims at: establishing the link between the atomic structure/composition and the physical properties of (nano)materials; designing, synthesizing and studying the first prototypes of molecular nano-machines; and inventing and/or developing new instruments and techniques able to study these 'objects' at the pertinent scales (space and time).
Can one establish a communication with a single molecule and get it to compute? How to guide light energy on a surface down to a single fluorescing molecule and trigger its emission? These two questions share the challenge to build new integrated architectures able to funnel electrons and photons through waveguides that shrink by a factor 1000 between the macroscopic and the single molecule worlds. The COMOSYEL project and team led by Erik DUJARDIN in CEMES and funded by the European Reseach Council (ERC) aim at tackling these fascinating concepts through several experimental approaches.
CeNTech was created as one of Germany's first centers for nanotechnology. Integrated into the densest network of universities in all over Europe in the German state of North Rhine-Westfalia (NRW), CeNTech provides the ideal environment to direct selected ideas and results of nanotechnological research into technical applications.
The CCNE's goal is goal is to develop and validate nanotechnology so that one will eventually be able to predict which patients will likely respond to a specific anti-cancer therapy and to monitor their response to therapy.
The Center for Cell Control is working to first utilize systems control, with therapeutic intent, to determine the parameters for guiding the cell to a directed phenotype/genotype which will then be followed by in depth study, using nanoscale modalities, of the path by which this desired state is achieved. This approach will enable engineering systems that can be applied towards the regulation of a spectrum of cellular functions, such as cancer eradication, controlling viral infection onset, and stem cell differentiation.
CINT is a Department of Energy/Office of Science Nanoscale Science Research Center (NSRC) operating as a national user facility devoted to establishing the scientific principles that govern the design, performance, and integration of nanoscale materials.
The Centre for Materials Discovery (CMD) is championing the use of High Throughput (HT) technologies across multiple industrial sectors within Merseyside and the Northwest of England. Competencies include materials synthesis for organic materials, polymers, porous materials, nanomaterials.
CMPND develops manufacturing protocols and nanostructures for near-term industrial polymeric nanocomposites, emerging polymer photonic components and devices, and more futuristic biomedical devices and systems with nanoscale functions.
CNMM is a joint venture between the University of Maryland and the National Institute of Standards and Technology. Its mission is to advance the science and technology of manufacturing and realization of products based on the use of the unique properties achieved at the nanoscale.